DK0487613T3 - Megakarycytopiesk faktor - Google Patents

Megakarycytopiesk faktor

Info

Publication number
DK0487613T3
DK0487613T3 DK90913091.6T DK90913091T DK0487613T3 DK 0487613 T3 DK0487613 T3 DK 0487613T3 DK 90913091 T DK90913091 T DK 90913091T DK 0487613 T3 DK0487613 T3 DK 0487613T3
Authority
DK
Denmark
Prior art keywords
factor
megakarycytopic
megakaryocytopoietic
megakaryocytes
colonies
Prior art date
Application number
DK90913091.6T
Other languages
English (en)
Inventor
Steven C Clark
Rodney M Hewick
Thomas G Gesner
Katherine Turner
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/546,114 external-priority patent/US5326558A/en
Application filed by Genetics Inst filed Critical Genetics Inst
Application granted granted Critical
Publication of DK0487613T3 publication Critical patent/DK0487613T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK90913091.6T 1989-08-08 1990-08-07 Megakarycytopiesk faktor DK0487613T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39090189A 1989-08-08 1989-08-08
US45719689A 1989-12-28 1989-12-28
US07/546,114 US5326558A (en) 1989-08-08 1990-06-29 Megakaryocytopoietic factor

Publications (1)

Publication Number Publication Date
DK0487613T3 true DK0487613T3 (da) 1996-11-25

Family

ID=27409968

Family Applications (2)

Application Number Title Priority Date Filing Date
DK015492A DK15492A (da) 1989-08-08 1990-08-07 En megakaryocytopoietisk faktor
DK90913091.6T DK0487613T3 (da) 1989-08-08 1990-08-07 Megakarycytopiesk faktor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK015492A DK15492A (da) 1989-08-08 1990-08-07 En megakaryocytopoietisk faktor

Country Status (9)

Country Link
EP (2) EP0487613B1 (da)
AT (1) ATE144780T1 (da)
AU (1) AU640686B2 (da)
CA (1) CA2064738A1 (da)
DE (1) DE69029040T2 (da)
DK (2) DK15492A (da)
ES (1) ES2094757T3 (da)
HU (1) HUT63441A (da)
WO (1) WO1991002001A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466780A4 (en) * 1989-04-03 1992-08-26 Genetics Institute, Inc. Megakaryocyte growth promoting activity
US6433142B1 (en) * 1989-08-08 2002-08-13 Genetics Institute, Llc Megakaryocyte stimulating factors
WO1992000319A1 (en) * 1990-07-02 1992-01-09 Hipple Cancer Research Center Human meg-csf protein and methods
CA2112492A1 (en) * 1991-06-28 1993-01-07 Hava Avraham A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors
US5795569A (en) * 1994-03-31 1998-08-18 Amgen Inc. Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
GEP20002180B (en) * 1994-03-31 2000-07-25 Amgen Inc Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
US5786335A (en) * 1995-11-06 1998-07-28 Warner-Lambert Company Sulfhydryl containing peptides for treating vascular disease

Also Published As

Publication number Publication date
DK15492D0 (da) 1992-02-07
HUT63441A (en) 1993-08-30
EP0732401A2 (en) 1996-09-18
WO1991002001A1 (en) 1991-02-21
AU6295790A (en) 1991-03-11
ATE144780T1 (de) 1996-11-15
AU640686B2 (en) 1993-09-02
CA2064738A1 (en) 1991-02-09
DK15492A (da) 1992-02-07
EP0732401A3 (en) 1997-05-14
EP0487613B1 (en) 1996-10-30
DE69029040T2 (de) 1997-02-27
DE69029040D1 (de) 1996-12-05
ES2094757T3 (es) 1997-02-01
HU9200385D0 (en) 1992-06-29
EP0487613A1 (en) 1992-06-03

Similar Documents

Publication Publication Date Title
AU549481B2 (en) Hair growing agent
DE3683266D1 (de) Antibiotikum a 40926 mannosyl aglycon.
DE3682767D1 (de) Antibiotika-a40926-n-acylaminoglycuronyl-aglykone und antibiotika-a40926-aglykone.
DK312688D0 (da) Glykkopeptid-antibiotika
ATE144780T1 (de) Megakaryocytopoietischer faktor
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
ES2108680T3 (es) Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
DK0529410T3 (da) Antibiotikum GE 2270 faktor C2a
DE69104022T2 (de) Antibiotisches zyklisches Hexapeptid.
GR3022706T3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
ES2129053T3 (es) Nuevos derivados de fosfolipidos.
GR3004095T3 (da)
ATE173921T1 (de) Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
DE69014196D1 (de) 3,6-diamino-2,5-pyrazindicarbonitril und ihre herstellung.
FR2652086B1 (fr) Compose nouveau d'origine vegetale, derive de l'acide cafeique, l'oraposide; composition a usage therapeutique et composition dermato-cosmetique le contenant.
ES2162992T3 (es) Uso de 3-alfa-hidroxi-5-alfa-androsta-16-eno como medicamento.